Arquivos brasileiros de cardiologia最新文献_第5页

Look Who is Coming Back? Enhancing Predictive Models for Hospital Readmission Post-CABG: Insights and Perspectives. 看看谁回来了？加强心血管造影术后再入院的预测模型：见解和观点。

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20240493

Stephan Lachtermacher

引用次数: 0

A Program to Optimize the Detection of Paroxysmal Atrial Fibrillation: The RITMO Study. 优化阵发性心房颤动检测的计划：RITMO 研究。

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20240235

Rodrigo Paashaus de Andrade, Priscila Valverde Oliveira Vitorino, Ana Luiza Lima Sousa, Roberto Dischinger Miranda, Bruno Augusto Alcova Nogueira, Elizabeth do Espírito Santo Cestário, Marcus Vinícius de Oliveira, Luiz Kencis Júnior, Fernando Cenci Tormen, Pablo de Oliveira Antunes, Ivan Di Beo, Luiz Eduardo Guiselli Gallina, Weimar Kunz Sebba Barroso

{"title":"A Program to Optimize the Detection of Paroxysmal Atrial Fibrillation: The RITMO Study.","authors":"Rodrigo Paashaus de Andrade, Priscila Valverde Oliveira Vitorino, Ana Luiza Lima Sousa, Roberto Dischinger Miranda, Bruno Augusto Alcova Nogueira, Elizabeth do Espírito Santo Cestário, Marcus Vinícius de Oliveira, Luiz Kencis Júnior, Fernando Cenci Tormen, Pablo de Oliveira Antunes, Ivan Di Beo, Luiz Eduardo Guiselli Gallina, Weimar Kunz Sebba Barroso","doi":"10.36660/abc.20240235","DOIUrl":"10.36660/abc.20240235","url":null,"abstract":"Background: Atrial fibrillation (AF) is the most common sustained arrythmia, but still underdiagnosed especially among asymptomatic patients.Objectives: To evaluate a simple strategy to optimize the identification of AF.Methods: Asymptomatic patients aged 65 years or older, with hypertension or heart failure (HF), were included. Data were inserted into the REDCap software platform. Patients were assessed for the risk for AF using the Stroke Risk Analysis (SRA) mathematical algorithm, which was applied on a one-hour electrocardiogram (ECG). All patients at high risk for AF were instructed to follow a home ECG protocol for seven days using a portable Kardia 6 (OMRON, AliveCor®). The Kolmogorov-test was used to test the normality of quantitative variables; those with normal distribution were expressed as mean and standard deviation. A p<0.05 was set as statistically significant.Results: A total of 423 patients were assessed; 15 were excluded due to absence of SRA, yielding a sample of 408 patients. In 13 (3.2%), AF was identified, 120 (29.4%) were considered at high risk and 275 (67.4%) without increased risk for AF. Of the 120 high-risk patients, 111 successfully completed the seven-day protocol with Kardia; at least one episode of AF was identified in 43 patients.Conclusion: The strategy adopted in the RITMO study was shown to be effective in identifying AF in asymptomatic elderly patients with hypertension or HF, with an incidence of 13.7% (56/408).","PeriodicalId":93887,"journal":{"name":"Arquivos brasileiros de cardiologia","volume":"121 9","pages":"e20240235"},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Use of Anticoagulant Therapy in Obese People: What is the Evidence for the Ideal Dose? 肥胖者使用抗凝疗法：理想剂量的证据是什么？

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20240496

Marcia M Noya-Rabelo, Eduardo Novaes, Renata Moll-Bernardes, Olga Souza

引用次数: 0

Resting Heart Rate to Assess Patients with Heart Failure: That is All We Need. 评估心衰患者的静息心率：这就是我们所需要的

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20240521

Humberto Villacorta

引用次数: 0

The Impact of Severe Heart Disease on Causes of Death and Survival after Disability Retirement. 严重心脏病对残疾退休后死亡原因和存活率的影响。

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20240068

Cesar Romaro Pozzobon, Gabriel Porto Soares, Ronir Raggio Luiz, Gláucia Maria Moraes de Oliveira

{"title":"The Impact of Severe Heart Disease on Causes of Death and Survival after Disability Retirement.","authors":"Cesar Romaro Pozzobon, Gabriel Porto Soares, Ronir Raggio Luiz, Gláucia Maria Moraes de Oliveira","doi":"10.36660/abc.20240068","DOIUrl":"10.36660/abc.20240068","url":null,"abstract":"Background: Noncommunicable diseases contribute to premature deaths and limitations. Disability retirement is linked to chronic conditions, particularly cardiovascular diseases. The II Brazilian Guideline for Severe Heart Disease established criteria for cardiovascular disease classification. However, there is a lack of research in this topic within federal institutions.Objectives: Evaluate the survival and causes of death among disabled retirees at UFRJ, focusing on the impact of severe heart disease.Methods: A retrospective cohort study based on retirement and death records over 15 years. Retirements were categorized into three groups: full retirement due to severe heart disease, full retirement due to other diseases and proportional. Causes of death were obtained from death certificates. Mortality rates, survival and the presence of matching diagnoses between retirement and death were evaluated. Chi-square, log-rank, Cox models, Kaplan-Meier curves were utilized. Statistical significance with a 95% confidence interval, considering p<0.05.Results: There were 630 retirements, 368 (51.4%) in females, with an average age of 52.9 (SD=7.8) years, and 169 (26.8%) deaths. Mortality was higher in professors (37.0%; p=0.113), in the age group between 65 and 70 years (48.4%; p=0.004), in males (34.0%; p=0.001), and in full retirements due to severe heart disease (41.5%; p<0.001). Matching diagnoses between retirement and death were more frequent in professors (74.1%; p=0.026) and in full retirements due to severe heart disease (72.7%; p<0.001).Conclusions: Severe heart disease diagnosis is associated with higher mortality and shorter survival in disabled retirees. Its frequent occurrence in retirement and death diagnoses underscores its significance in this context.","PeriodicalId":93887,"journal":{"name":"Arquivos brasileiros de cardiologia","volume":"121 9","pages":"e20240068"},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495571/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Do We Need New Echocardiographic Parameters for Transplant Recipients without Rejection? 对于无排斥反应的移植受者，我们是否需要新的超声心动图参数？

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20240452

Alberto Rodolpho Hüning, Vitor Emer Egypto Rosa

引用次数: 0

Percutaneous Coronary Intervention Induced-No-reflow in Saphenous Vein Grafts. 经皮冠状动脉介入治疗诱发的无隐静脉移植物血流不畅。

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20240317

Yücel Kanal

引用次数: 0

Electrocardiogram as a Predictor of Mortality in Individuals with Pulmonary Hypertension. 心电图作为肺动脉高压患者死亡率的预测指标。

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20240548

Frederico José Neves Mancuso

引用次数: 0

One Hundred Years of the Nobel Prize for Electrocardiography: A Technology Still Essential and Fit for the Next Century. 心电图获得诺贝尔奖一百年：一项依然重要并适合下个世纪的技术。

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20240494

Eduardo M Vilela, Nuno Bettencourt

引用次数: 0

Fondaparinux versus Enoxaparin in the Treatment of Obese Patients with Acute Coronary Syndrome. 丰达肝癸与依诺肝素在急性冠状动脉综合征肥胖患者治疗中的对比。

Arquivos brasileiros de cardiologia Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.36660/abc.20230793

Beatriz Rocha Darzé, Carolina Costa da Silva Souza, Queila Borges de Oliveira, João Victor Santos Pereira Ramos, Mateus S Viana, Eduardo Sahade Darzé, Luiz Eduardo Fonteles Ritt

{"title":"Fondaparinux versus Enoxaparin in the Treatment of Obese Patients with Acute Coronary Syndrome.","authors":"Beatriz Rocha Darzé, Carolina Costa da Silva Souza, Queila Borges de Oliveira, João Victor Santos Pereira Ramos, Mateus S Viana, Eduardo Sahade Darzé, Luiz Eduardo Fonteles Ritt","doi":"10.36660/abc.20230793","DOIUrl":"10.36660/abc.20230793","url":null,"abstract":"Background: Fondaparinux is an effective and safe anticoagulant in the treatment of acute coronary syndromes (ACS). However, due to the low representation of obese individuals in clinical trials, the effects of applying the results of this drug to this population remain uncertain.Objectives: To compare Fondaparinux to Enoxaparin in the treatment of obese patients with ACS.Methods: This is a retrospective cohort study, including obese individuals (BMI ≥ 30 Kg/m2) admitted with non-ST-segment elevation myocardial infarction (NSTEMI) or unstable angina (UA) and treated with Fondaparinux or Enoxaparin between 2010 and 2020. The Fondaparinux and Enoxaparin groups were compared for their clinical and laboratory characteristics using chi-square and Mann-Whitney tests, as appropriate. The incidence of primary outcomes (death, reinfarction, stroke, major bleeding) was compared between groups. P-value < 0.05 was considered significant for all analyses.Results: A total of 367 obese patients with NSTEMI or UA were included, of whom 258 used Fondaparinux and 109 used Enoxaparin. Mean age was 64 ± 12 years, and 52.9% were male. The prevalence of diabetes, hypertension, dyslipidemia, prior coronary artery disease, prior stroke, and implementation of invasive strategy was similar between groups. The incidence of the primary outcome was 4.7% in the Fondaparinux group and 5.5% in the Enoxaparin group (p = 0.729). There was no difference between groups when analyzing the components of the primary outcome separately.Conclusion: In a sample of obese patients with NSTEMI or UA, there was no difference in the occurrence of the composite outcome (death, stroke, reinfarction, major bleeding) between patients who used Fondaparinux or Enoxaparin.","PeriodicalId":93887,"journal":{"name":"Arquivos brasileiros de cardiologia","volume":"121 8","pages":"e20230793"},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0